Big Pharma HATES This Anti-Aging Secret (What Doctors Aren't Telling You)
Shaheen Amir, a former extreme athlete and entrepreneur, shares his transition into longevity and peptide therapy, attributing his improved health at 53 to self-experimentation with peptides, stem cells, and rigorous recsummaryHe critiques the pharmaceutical industry's profit motives, warns against the risks of unregulated online peptide markets (particularly Chinese sourcing), and advocates for conservative dosing, blood work monitoring, and summaryPharmaceutical industry prioritizes quarterly profits over patient health, leading to restrictions on curative treatments like stem cells and peptides to maintain recurring revenue from chronic disease management.takeaway




